Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001468308-26-000028

CHIEF FINANCIAL OFFICER sold 75,000 shares at $11.78 ($883,500)

  • CHIEF FINANCIAL OFFICER acquired 21,928 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Andrade Robert · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-27 Sale : show line 1 in the form 10b5-1 −75,000 $11.78 $883,500 217,675 D
2026-08-28 Exercise or conversion : show line 2 in the form 10b5-1 +21,928 $5.10 $111,833 239,603 D
Open-market sales · 75,000 sh · avg $11.78 · $883,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-28 Exercise or conversion : show line 3 in the form 10b5-1 Stock Options −21,928 779,330 D
Loading xslF345X06/form4-08282026_090813.xml…